home / stock / tngx / tngx short
Short Information | Tango Therapeutics Inc. (NASDAQ:TNGX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,759,887 |
Total Actual Volume | 9,854,782 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 87,994 |
Average Short Percentage | 18.17% |
Is there a TNGX Short Squeeze or Breakout about to happen?
See the TNGX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-20-2024 | $7.52 | $7.67 | $7.73 | $7.44 | 295,490 | 59,020 | 19.97% |
05-17-2024 | $7.83 | $7.52 | $7.83 | $7.39 | 430,285 | 121,655 | 28.27% |
05-16-2024 | $7.82 | $7.79 | $7.96 | $7.76 | 395,217 | 101,354 | 25.65% |
05-15-2024 | $7.76 | $7.8 | $7.97 | $7.67 | 612,793 | 57,927 | 9.45% |
05-14-2024 | $7.32 | $7.6 | $7.64 | $7.32 | 415,334 | 83,249 | 20.04% |
05-13-2024 | $7.21 | $7.31 | $7.625 | $7.15 | 365,079 | 66,853 | 18.31% |
05-10-2024 | $7.82 | $7.105 | $7.97 | $6.92 | 453,390 | 73,332 | 16.17% |
05-09-2024 | $7.82 | $7.77 | $8.38 | $7.71 | 793,362 | 110,081 | 13.88% |
05-08-2024 | $7.7 | $7.91 | $7.96 | $7.43 | 664,461 | 135,544 | 20.4% |
05-07-2024 | $7.9 | $7.85 | $8.06 | $7.79 | 490,607 | 119,685 | 24.4% |
05-06-2024 | $7.6 | $7.89 | $8.02 | $7.52 | 446,370 | 78,338 | 17.55% |
05-03-2024 | $7.76 | $7.61 | $7.93 | $7.49 | 345,845 | 36,817 | 10.65% |
05-02-2024 | $7.32 | $7.59 | $7.67 | $7.32 | 477,762 | 80,918 | 16.94% |
05-01-2024 | $7.51 | $7.28 | $7.805 | $7.2 | 887,165 | 142,397 | 16.05% |
04-30-2024 | $7.75 | $7.7 | $8.02 | $7.675 | 651,508 | 94,064 | 14.44% |
04-29-2024 | $7.45 | $7.87 | $7.88 | $7.4 | 433,583 | 90,779 | 20.94% |
04-26-2024 | $7.37 | $7.44 | $7.5 | $7.26 | 301,906 | 49,114 | 16.27% |
04-25-2024 | $7.54 | $7.33 | $7.58 | $7.18 | 447,982 | 98,577 | 22% |
04-24-2024 | $7.75 | $7.76 | $7.8 | $7.49 | 364,902 | 43,719 | 11.98% |
04-23-2024 | $7.36 | $7.77 | $7.92 | $7.3 | 581,741 | 116,464 | 20.02% |
News, Short Squeeze, Breakout and More Instantly...
Tango Therapeutics Inc. Company Name:
TNGX Stock Symbol:
NASDAQ Market:
– Dose expansion initiated in TNG908 phase 1/2 clinical trial – – Dose expansion expected to initiate in TNG462 phase 1/2 clinical trial in 2Q 2024 – – Clinical data expected in 2H 2024 from PRMT5 program – – Dose escalation...
– Dose escalation ongoing in four clinical-stage precision oncology programs; TNG908 phase 1/2 clinical data expected in 2024 – – First patient dosed in phase 1/2 clinical trial of TNG348 in patients with BRCA1/2-mutant and other HRD+ cancers – –...